GRAY-ZONE LYMPHOMA
Clinical trials for GRAY-ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRAY-ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for GRAY-ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test powerful new drug cocktail to fight Fast-Growing lymphomas
Disease control Recruiting nowThis early-stage study is testing the safety of adding one or two new targeted drugs to a standard chemotherapy regimen for people with untreated, fast-growing B-cell lymphomas. The goal is to see if this combination is tolerable for patients and to gather initial data on its eff…
Matched conditions: GRAY-ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo aims to tame resistant blood cancers
Disease control Recruiting nowThis study is testing if adding the drug ruxolitinib to the immunotherapy pembrolizumab is safe and can help control several types of lymphoma that have returned or resisted standard chemotherapy. It is for adults with specific T-cell or B-cell lymphomas who have tried at least o…
Matched conditions: GRAY-ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Seda S. Tolu • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC